Seer, Inc. (SEER)

1.7500 -0.0200 (-1.13%) At close: 04:00PM EDT

Seer, Inc.

3800 Bridge Parkway
Suite 102
Redwood City, CA 94065
United States
650 453 0000
https://seer.bio

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 147

Key executives

Name	Title	Pay	Exercised	Year born
Dr. Omid C. Farokhzad M.D., Ph.D.	Founder, CEO, & Chair of the Board of Directors	1.23M	N/A	1969
Mr. David R. Horn	President,Treasurer & CFO	593.38k	N/A	1967
Ms. Elona Kogan Esq., J.D.	Chief Legal Officer,General Counsel & Secretary	548.42k	N/A	1969
Mr. Joe Laws	Chief Technology Officer and Co-Founder	N/A	N/A	N/A
Kenny Ross	Chief Operations & Product Officer	N/A	N/A	N/A
Ms. Marissa Dixon	Chief People Officer	N/A	N/A	N/A
Dr. Serafim Batzoglou Ph.D.	Chief Data Officer	N/A	N/A	N/A
Mr. Martin Goldberg Ph.D.	Senior Vice President of Development	N/A	N/A	N/A
Dr. Asim Siddiqui Ph.D.	Senior Vice President of Research & Tech Development	N/A	N/A	N/A
Dr. Christopher E. Mason Ph.D.	Member of Scientific Advisory Board	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Corporate governance

Seer, Inc.’s ISS governance QualityScore as of 1 April 2024 is 10. The pillar scores are Audit: 8; Board: 8; Shareholder rights: 10; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.